Flemming Ørnskov
Born1957 or 1958 (age 65–66)[1]
NationalityDanish
Alma materUniversity of Copenhagen
INSEAD
Harvard University
Occupation(s)CEO, Galderma

Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma[2] since October 2019.

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.[3] He previously worked for Bayer, Bausch & Lomb and Novartis.[2]

He is also the chairman of Waters Corporation.[4]

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[1]

Awards

Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review[5]

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech[6]

References

  1. 1 2 "Executive Profile: Flemming Ornskov". Bloomberg. Retrieved 4 September 2017.
  2. 1 2 Liu, Angus (October 8, 2019). "Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout". Fiercepharma.
  3. ↑ "Shire chief finds right prescription for growth". The Telegraph. Retrieved 20 March 2014.
  4. ↑ "Conseil d'administration : Waters". www.waters.com. Retrieved 2021-04-01.
  5. ↑ "The 'best-performing' CEO in the world is a pharma chief". BioPharma Dive. Retrieved 2021-04-01.
  6. ↑ "The 25 most influential people in biopharma today - 2013". FierceBiotech. Retrieved 2021-04-01.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.